Effect of permeation enhancers and organic acids on the skin permeation of indapamide

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 43-47

  Ren, Changshun ^a   Fang, Liang ^a   Li, Ting ^a   Wang, Manli ^a   Zhao, Ligang ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

In vitro; Indapamide; Organic acids; Percutaneous absorption; Permeation enhancers

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ACETIC ACID; ADIPIC ACID; CARBOXYLIC ACID; CITRIC ACID; FUMARIC ACID; INDAPAMIDE; LACTIC ACID; MALEIC ACID; MENTHOL; N DODECYLAZEPAN 2 ONE; OLEIC ACID; OXALIC ACID; PENETRATION ENHANCING AGENT; SUCCINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; SKIN PENETRATION; SKIN PERMEABILITY;

ACIDS; ANIMALS; ETHANOL; INDAPAMIDE; MALE; ORGANIC CHEMICALS; PERMEABILITY; PROPYLENE GLYCOL; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY;

EID: 38349156653     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.020     Document Type: Article

References (18)

1. Aiguo S., Jing S., and Weimin Sh. The adverse drug reaction of indapamide. Pract. J. Med. Pharm. 11 (2003) 843-844
2. Benson H.A.E. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2 (2005) 23-33
3. Chaffman M., Heel R.C., Brogden R.N., Speight T.M., and Avery G.S. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 28 (1984) 189-235
4. Chang S.L., and Banga A.K. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions. J. Pharm. Pharmacol. 50 (1998) 635-640
5. Chattaraj S.C., and Walker R.B. Penetration enhancer classification. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (1995), CRC Press, Boca Raton, FL 5-20
6. Fang L., Kobayashi Y., Numajiri S., Kobayashi D., Sugibayashi K., and Morimoto Y. The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol. Pharm. Bull. 25 (2002) 1339-1344
7. Hadgraft J., and Lane M. Passive transdermal drug delivery systems: recent considerations and advances. Am. J. Drug Deliv. 4 (2006) 153-160 8
8. Jianliang Zh., Yongwen Q., Xing Zh., Jianli Q., Jiang C., and Rongliang X. Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports). Diabetes Res. Clin. Pract. 65 (2004) 243-246
9. Kobayashi Y., Nakamura H., Sugibayashi K., and Morimoto Y. Estimation of action site of l-lacetic acid-ethanol-isopropyl myristate mixed system for its enhancing effect on the skin permeation of ketotifen. Int. J. Pharm. 156 (1997) 153-162
10. McDaid D.M., and Deasy P.B. Formulation development of a transdermal drug delivery system for amlodipine base. Int. J. Pharm. 133 (1996) 71-83
11. Mezel M. Liposomes as a skin drug delivery system. In: Breimer D.D., and Speiser P. (Eds). Topics in Pharmaceutical Sciences (1985), Elsevier, Amsterdam 345-358
12. Morimoto K., Iwakura Y., Nakatani E., Miyazaki M., and Tojima H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J. Pharm. Pharmacol. 44 (1992) 216-218
13. Nakamura H., Pongpaibul Y., Hayashi T., Sugibayashi K., and Morimoto Y. Effect of lipophilic multicomponent system on the skin permeation of ketotifen fumarate. Int. J. Pharm. 141 (1996) 71-80
14. Nakamura H., kobayashi Y., Sugibayashi K., and Morimoto K. The effects of the l-lactic acid-ethanol-isopropyl myristate mixed system on the skin permeation of several drugs. Drug Deliv. Syst. 12 (1997) 101-106
15. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3 (2004) 115-124
16. Sloan K.B., Selk S., Haslam J., Caldwell L., and Shaffer R. Acyloxyamines as prodrugs of anti-inflammatory carboxylic acids for improved delivery through skin. J. Pharm. Sci. 73 (1984) 1734-1737
17. Smith E.W., and Maibach H.I. Percutaneous penetration enhancers: the fundamentals. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (1995), CRC Press, Boca Raton, FL 1-4
18. Vavrova K., Zbytovska J., and Hrabalek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr. Med. Chem. 12 (2005) 2273-2291 19